ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $393,805,000 | +193.7% | 8,500,000 | +54.5% | 2.56% | +154.1% |
| Q1 2019 | $134,090,000 | +63.6% | 5,500,000 | -4.3% | 1.01% | +67.7% |
| Q4 2018 | $81,938,000 | +5.2% | 5,750,000 | +12.2% | 0.60% | +30.7% |
| Q3 2018 | $77,900,000 | -0.2% | 5,125,000 | +10.2% | 0.46% | -4.6% |
| Q2 2018 | $78,027,000 | +54.5% | 4,650,000 | +50.2% | 0.48% | +37.7% |
| Q1 2018 | $50,510,000 | – | 3,095,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,169,276 | $66,110,000 | 11.67% |
| Redmile Group, LLC | 13,623,620 | $98,226,000 | 8.05% |
| First Light Asset Management, LLC | 849,374 | $6,124,000 | 2.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,529,361 | $68,707,000 | 2.29% |
| Opus Point Partners Management, LLC | 320,000 | $2,307,000 | 1.83% |
| KOPP INVESTMENT ADVISORS LLC | 383,022 | $2,762,000 | 1.23% |
| Artal Group S.A. | 3,710,000 | $26,749,000 | 1.15% |
| EcoR1 Capital, LLC | 400,000 | $2,884,000 | 0.96% |
| Cormorant Asset Management, LP | 850,000 | $6,129,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,768,000 | 0.56% |